| Breakdown | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.05B | 6.13B | 5.32B | 4.62B | 4.20B |
| Gross Profit | 5.43B | 4.88B | 4.29B | 3.72B | 3.34B |
| EBITDA | 2.50B | 1.85B | 1.56B | 1.33B | 1.01B |
| Net Income | 1.33B | 2.26B | 1.23B | 984.59M | 757.52M |
Balance Sheet | |||||
| Total Assets | 48.22B | 13.07B | 10.33B | 9.42B | 8.75B |
| Cash, Cash Equivalents and Short-Term Investments | 2.96B | 4.05B | 1.59B | 1.57B | 1.58B |
| Total Debt | 14.29B | 684.46M | 677.60M | 656.37M | 666.77M |
| Total Liabilities | 19.90B | 4.05B | 4.15B | 3.86B | 3.45B |
| Stockholders Equity | 28.33B | 8.99B | 6.15B | 5.52B | 5.30B |
Cash Flow | |||||
| Free Cash Flow | 1.35B | 1.28B | 1.51B | 1.60B | 1.40B |
| Operating Cash Flow | 1.52B | 1.41B | 1.70B | 1.74B | 1.49B |
| Investing Cash Flow | -15.91B | 1.22B | -482.10M | -572.62M | -549.03M |
| Financing Cash Flow | 13.39B | -181.30M | -1.20B | -1.12B | -748.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $108.03B | 15.52 | 55.43% | ― | 10.53% | 34.24% | |
72 Outperform | $60.00B | 33.66 | 135.72% | ― | 14.78% | 22.52% | |
72 Outperform | $124.32B | 83.55 | 16.26% | ― | 15.30% | -60.71% | |
69 Neutral | $84.62B | 55.14 | 7.16% | ― | 12.62% | -45.12% | |
65 Neutral | $448.85B | 29.35 | 70.60% | 1.00% | 11.08% | 29.56% | |
62 Neutral | $27.45B | ― | -2.41% | ― | 23.24% | -8.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
On February 14, 2026, Synopsys’ board expanded from eleven to twelve members and appointed former Deloitte executive Peter A. Shimer as an independent director and audit committee member, effective immediately. Shimer, an audit committee financial expert with four decades at Deloitte and current roles at Alaska Air Group and cancer-focused AI initiatives, will receive standard non-employee director compensation, reinforcing Synopsys’ financial oversight as it scales its AI-driven silicon-to-systems platform.
In a related February 19, 2026 announcement, Synopsys said it would not renominate directors Luis Borgen and Dr. Ajei Gopal for re-election, though both will serve until the 2026 annual meeting. The board framed these moves, which come as the Ansys integration progresses, as part of a broader commitment to director refreshment and governance evolution to support the company’s leadership in the growing silicon-to-systems engineering market.
The most recent analyst rating on (SNPS) stock is a Buy with a $560.00 price target. To see the full list of analyst forecasts on Synopsys stock, see the SNPS Stock Forecast page.
On December 1, 2025, Synopsys, Inc. and NVIDIA Corporation announced an expanded strategic partnership, marked by NVIDIA’s $2 billion investment in Synopsys’ common stock. This collaboration aims to revolutionize design and engineering across industries by integrating NVIDIA’s AI and accelerated computing with Synopsys’ engineering solutions. The partnership will focus on enhancing simulation speed and scale, advancing AI engineering, and developing digital twins, thereby opening new market opportunities and enabling more efficient innovation for R&D teams in sectors such as semiconductor, aerospace, and automotive.
The most recent analyst rating on (SNPS) stock is a Buy with a $510.00 price target. To see the full list of analyst forecasts on Synopsys stock, see the SNPS Stock Forecast page.